The introduction of Retatrutide ZPHC, at a strength of 120mg, is generating considerable buzz within the medical community. This innovative dual GIP and GLP-1 receptor medication seems to offer significant improvements in body loss compared to current therapies. Early clinical trials have indicated significant decreases in body fat percentage, poss